Search

Your search keyword '"Canafoglia, L."' showing total 351 results

Search Constraints

Start Over You searched for: Author "Canafoglia, L." Remove constraint Author: "Canafoglia, L."
351 results on '"Canafoglia, L."'

Search Results

1. A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study

4. GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture

5. A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: 'Precision medicine' approach with fluoxetine

6. IRF2BPL: A new genotype for progressive myoclonus epilepsies

7. A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet

8. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study

9. Brivaracetam as add-on treatment in focal epilepsy: A real-world time-based analysis

10. Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy

13. Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, RealWorld Study

14. Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy

15. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)

16. Progressive epileptic encephalopathy associated with a novel HCN2 mutation

17. Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3

18. Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3)

19. Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 10.1007/s40263-021-00856-3)

20. Progressive Myoclonus Epilepsies Diagnostic Yield With Next-Generation Sequencing in Previously Unsolved Cases

21. Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals

23. Polygenic burden in focal and generalized epilepsies

24. Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy

26. DISTRIBUTION OF PROGRESSIVE MYOCLONUS EPILEPSIES IN ITALY; POSITIVELY DIAGNOSED AND UNCLASSIFIED PATIENTS: p827

28. Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy

30. HCN1 novel mutations in familiar generalized epilepsy

32. Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3

34. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

35. Intronic ATTTC repeat expansions in STARD7 in familial adult myoclonic epilepsy linked to chromosome 2

36. Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3

37. HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature

38. Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes

40. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

46. A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability

47. HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond

48. A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability

49. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

50. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study

Catalog

Books, media, physical & digital resources